von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. 2002

Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
Mario Negri Institute for Pharmacological Research, Clinical Research Center for Rare Diseases, Aldo e Cele Daccò, Villa Camozzi-Ranica, Bergamo, Italy.

Whether measurement of ADAMTS13 activity may enable physicians to distinguish thrombotic thrombocytopenic purpura (TTP) from hemolytic uremic syndrome (HUS) is still a controversial issue. Our aim was to clarify whether patients with normal or deficient ADAMTS13 activity could be distinguished in terms of disease manifestations and multimeric patterns of plasma von Willebrand factor (VWF). ADAMTS13 activity, VWF antigen, and multimeric pattern were evaluated in patients with recurrent and familial TTP (n = 20) and HUS (n = 29). Results of the collagen-binding assay of ADAMTS13 activity were confirmed in selected samples by testing the capacity of plasma to cleave recombinant VWF A1-A2-A3. Most patients with TTP had complete or partial deficiency of ADAMTS13 activity during the acute phase, and in some the defect persisted at remission. However, complete ADAMTS13 deficiency was also found in 5 of 9 patients with HUS during the acute phase and in 5 patients during remission. HUS patients with ADAMTS13 deficiency could not be distinguished clinically from those with normal ADAMTS13. In a subgroup of patients with TTP or HUS, the ADAMTS13 defect was inherited, as documented by half-normal levels of ADAMTS13 in their asymptomatic parents, consistent with the heterozygous carrier state. In patients with TTP and HUS there was indirect evidence of increased VWF fragmentation, and this occurred also in patients with ADAMTS13 deficiency. In conclusion, deficient ADAMTS13 activity does not distinguish TTP from HUS, at least in the recurrent and familial forms, and it is not the only determinant of VWF abnormalities in these conditions.

UI MeSH Term Description Entries
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D008297 Male Males
D008666 Metalloendopeptidases ENDOPEPTIDASES which use a metal such as ZINC in the catalytic mechanism. Metallo-Endoproteinases,Metalloendopeptidase
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011697 Purpura, Thrombotic Thrombocytopenic An acquired, congenital, or familial disorder caused by PLATELET AGGREGATION with THROMBOSIS in terminal arterioles and capillaries. Clinical features include THROMBOCYTOPENIA; HEMOLYTIC ANEMIA; AZOTEMIA; FEVER; and thrombotic microangiopathy. The classical form also includes neurological symptoms and end-organ damage, such as RENAL FAILURE. Mutations in the ADAMTS13 PROTEIN gene have been identified in familial cases. Moschkowitz Disease,Purpura, Thrombotic Thrombopenic,Thrombotic Thrombocytopenic Purpura, Congenital,Thrombotic Thrombocytopenic Purpura, Familial,Congenital Thrombotic Thrombocytopenic Purpura,Familial Thrombotic Thrombocytopenia Purpura,Familial Thrombotic Thrombocytopenic Purpura,Microangiopathic Hemolytic Anemia, Congenital,Moschcowitz Disease,Schulman-Upshaw Syndrome,Thrombotic Microangiopathy, Familial,Thrombotic Thrombocytopenic Purpura,Upshaw Factor, Deficiency of,Upshaw-Schulman Syndrome,Familial Thrombotic Microangiopathy,Microangiopathy, Familial Thrombotic,Schulman Upshaw Syndrome,Thrombocytopenic Purpura, Thrombotic,Thrombopenic Purpura, Thrombotic,Thrombotic Thrombopenic Purpura,Upshaw Schulman Syndrome
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005192 Family Health The health status of the family as a unit including the impact of the health of one member of the family on the family as a unit and on individual family members; also, the impact of family organization or disorganization on the health status of its members. Health, Family
D005260 Female Females
D006463 Hemolytic-Uremic Syndrome A syndrome that is associated with microvascular diseases of the KIDNEY, such as RENAL CORTICAL NECROSIS. It is characterized by hemolytic anemia (ANEMIA, HEMOLYTIC); THROMBOCYTOPENIA; and ACUTE RENAL FAILURE. Gasser's Syndrome,Gasser Syndrome,Gassers Syndrome,Hemolytic Uremic Syndrome,Syndrome, Hemolytic-Uremic

Related Publications

Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
January 2000, Advances in nephrology from the Necker Hospital,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
April 1999, The New England journal of medicine,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
April 1999, The New England journal of medicine,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
July 2002, Blood,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
November 2003, MLO: medical laboratory observer,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
July 2003, Expert review of cardiovascular therapy,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
March 2006, Seminars in thrombosis and hemostasis,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
November 2001, The Journal of biological chemistry,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
April 1990, Transfusion medicine reviews,
Giuseppe Remuzzi, and Miriam Galbusera, and Marina Noris, and Maria Teresa Canciani, and Erica Daina, and Elena Bresin, and Silvia Contaretti, and Jessica Caprioli, and Sara Gamba, and Piero Ruggenenti, and Norberto Perico, and Pier Mannuccio Mannucci, and
June 1998, Bailliere's clinical haematology,
Copied contents to your clipboard!